This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Baylor College of Medicine. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Feiyan Mo: Advancing Targeted Immune-Cell Therapies.
Introduction
Feiyan Mo is an inventor associated with Baylor College of Medicine in Houston, Texas. Her work includes an invention focused on selectively targeting activated pathogenic T cells and natural killer (NK) cells.
Latest Patents
Mo is listed as an inventor on 1 patent: “Auto/Allo-Immune Defense Receptors for the Selective Targeting of Activated Pathogenic T Cells and NK Cells.” The invention concerns receptors designed to recognize and target activated immune cells.
Career Highlights
Mo’s patent record reflects research connected to immune-cell targeting and therapeutic approaches. The available information identifies Baylor College of Medicine as her institutional affiliation.
Collaborations
The patent lists Maksim Mamonkin and Malcolm K. Brenner among Mo’s fellow inventors, indicating collaborative work on the receptor technology.
Conclusion
Feiyan Mo’s documented invention, developed in collaboration with colleagues at Baylor College of Medicine, addresses selective targeting of activated pathogenic T cells and NK cells.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile